- We expect Pidilite to post ~21% revenue growth to INR7.86, led by 8-9% volume growth in consumer and bazaar segments, even as industrial chemicals remains under pressure.
- VAM prices have been declining for a while now; however, the benefit has been negated by INR depreciation.
- EBITDA margin is also expected to increase by 40bp YoY to 15.1% on account of higher gross margin and operating leverage.
- PAT is expected to register 12% YoY growth to INR837m.
- Uncertainty regarding the synthetic elastomer project continues and the company is yet to take a call on the project's implementation.
- The stock trades at 26.2x FY14E EPS and 21.7x FY15E EPS. Maintain Buy.